Partner

At a glance

1

Finished Products

1

Therapy Areas

1+

Delivery Formats

C3-CURA™

Primary Platform

All products
PolicosanolIngredient · 13/14

Policosanol

Long-chain aliphatic alcohol

Market Landscape

The opportunity – and where the market falls short.

  • 01Lipid modulator – supports LDL reduction and HDL improvement
  • 02Cardiovascular support – vascular health, circulation, long-term heart function
  • 03Natural alternative to synthetic lipid-lowering agents
  • 04Synergistic use with actives like curcumin
  • 05Preventive relevance for cardiometabolic management
The Stabicon Edge

From market limitation to measurable transformation.

Market LimitationStabicon TransformationImpact
Low Market AwarenessPreventive Positioning – early lipid managementRelevance in proactive cardiovascular care
Limited Clinical PositioningIntegrated Cardio-Metabolic ApproachAdoption in wellness and therapeutic segments
Format ConstraintsSimplified Oral Tablet FormatsUsability and compliance
Lack of CombinationsCombination Strategy – Policosanol + CurcuminDual-action efficacy
Weak DifferentiationMulti-Pathway Value PropositionClear product differentiation
Missed Preventive SegmentCardio-Metabolic Portfolio IntegrationScalable preventive portfolio
Stabicon's Portfolio

Policosanol reimagined across therapy areas and delivery formats.

Every finished product powered by Policosanol. Filter by therapy area, and tap any ingredient to open its market landscape and Stabicon edge.

Filter
1 product

Swipe or drag to explore

TRUST Curcumin + Policosanol Tablet

General Wellness

TRUST Curcumin + Policosanol Tablet

Curcumin-policosanol combination for lipid and cardiovascular wellness.

An oral combination designed to pair curcumin's metabolic and inflammatory support with policosanol-led lipid-management positioning.

Key Ingredients

Key Benefits

  • Supports healthy lipid balance, cardiovascular wellness and metabolic inflammatory balance

ForAdults

FormatsTablet

A dual-active combination offers a differentiated entry into the large cholesterol and preventive cardiometabolic wellness market.

Stabicon Life Sciences

Science-Led Formulations. Scalable Health Platforms.

Offices

Corporate Office

22, 7th Cross, Jaibharath Nagar, Bengaluru 560 033, Karnataka, India

Research & Development

28, Bommasandra Industrial Area, 4th Phase, Jigani Hobli, Anekal Taluk, Bengaluru 560 099, Karnataka, India

Newsletter

Quarterly briefings on platforms, science & partnerships.

No spam. Unsubscribe in one click. Your email stays with us.

Press Kit

Logos, fact sheet & spokesperson bios – all in one download.

Download Press Kit (ZIP)

For media queries: press@stabicon.com

Accreditations

ISO/IEC 17025:2017 (NABL)WHO Geneva – Audited & ApprovedFSSAI ApprovedCDSCO IndiaUS FDA – Registered FacilityDSIR RegisteredAYUSH Registered

Disclaimer: The information provided on this website is for educational and informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. These statements have not been evaluated by the Food and Drug Administration (FDA). This product is not intended to diagnose, treat, cure, or prevent any disease. Product packaging and materials may vary from those shown on our website. We recommend that you do not rely solely on the information presented and that you always read labels, warnings, and directions before using or consuming a product.

© 2026 Stabicon Life Sciences Pvt. Ltd. All rights reserved.

Science-Led Formulations. Scalable Health Platforms.

Admin